Abstracts

378 – HIV Drives CARD8 Inflammasome Activation and Proinflammatory Cytokine Release by Myeloid Cells

Background Inflammasome activation in response to “danger-associated stimuli” including HIV can lead to the release of inflammatory cytokines such as IL-1ß and IL-18 as well as pyroptotic cell death. The HIV-1 protease can activate the CARD8 inflammasome in CD4 T cells, resulting in T-cell loss during untreated HIV infection. Since myeloid cells are equipped to…

364 – Secreted ORF8 Reprograms Macrophages to Enhance Lung Epithelial Cell Infection by SARS-CoV-2

Background ORF8 is an accessory protein encoded by SARS-CoV-2, containing an immunoglobulin-like domain of approximately 20 kDa, and is secreted extracellularly by infected cells. Serum levels of ORF8 have been shown to correlate with disease severity in COVID-19 patients, though its exact function and target cells remain unknown. We hypothesized that extracellular ORF8 influences COVID-19…

396 – Clinical and Immune Characteristics of ART+SIV/P. fragile Infected Macaques With Persistent Viremia

Background Despite the efficacy of contemporary antiretroviral therapy (ART) regimens, some people with HIV (PWH) experience persistent low-level viremia (pLLV). pLLV risk factors include poor ART adherence, high viral loads (VLs) pre-ART, and co-infection. Importantly, HIV and malaria, caused by Plasmodium infection, are geographically co-endemic and both pathogens persist in the gastrointestinal (GI) tract. However,…

359 – Single-Cell Multi-Omics Uncovers the Immune Heterogeneity in HIV-Infected INRs

Background Immunological non-responders (INRs) are people living with HIV-1 who fail to achieve full immune reconstitution despite long-term effective antiretroviral therapy (ART). This incomplete recovery of CD4+ T cells increase the risk of opportunistic infections and non-AIDS-related morbidity and mortality. Understanding the mechanisms driving this immune dysfunction is critical for developing targeted therapies.  Methods We…

386 – Living With HIV Mimics the Proinflammatory FUT2 Non-Secretor Phenotype in the Intestines

Background The genetic FUT2 non-secretor status is phenotypically characterized by low levels of the glycan α1,2 fucose. Fucose in the intestines plays a crucial role in maintaining homeostasis between the gut and its microbiota, and loss of fucose can impair intestinal function and promote inflammation. While intestinal dysfunction and inflammation are well-documented in people with…

337 – Vitamins K2 and D3 Improve Long COVID Index, Fungal Translocation, and Inflammatory Biomarkers

Background Long COVID (LC) is characterized by recurrent, prolonged, and new symptoms of COVID-19 at least 3 months after a SARS-COV-2 infection. LC was associated with fungal translocation, gut dysfunction, and enhanced inflammation. The anti-inflammatory vitamins K2/D3 were previously shown to reduce inflammation and help attenuate the course of acute COVID infection. This trial aims…

367 – Activated Platelets Render Functionally Deficient Natural Killer Cells in People Living With HIV

Background Anti-retroviral therapy (ART) for people with HIV (PWH) is very effective in suppressing HIV replication and preventing disease progression. However, even while on ART, NK cells remain dysfunctional. Although the exact mechanism of this dysfunction is unknown, there is evidence of increased platelet-immune cell complex formation in PWH. These complexes alter immune cell functions,…

334 – The Bile Acids Complexity Underlies an Antiviral Interferon Innate Signaling During COVID-19 Disease

Background Bile acids (BAs), synthesized by hepatocytes (primary BAs) and modified by commensal bacteria (secondary BAs), are important regulators of immune cell function, particularly in innate immunity. While the role of BAs in influencing immune responses to various viral infections is established, the specific impact of nonsulfated BAs on immune cells remains underexplored. BAs can…

333 – Bile Acids in the Modulation of Antiviral Immune Response

Background Bile acids (BAs) are produced from cholesterol in the liver as primary BAs and modified by gut microbiota becoming secondary BAs. Besides their primary role in solubilizing fats, these metabolites have been shown to modulate innate and adaptive immune function, making BAs a link between host metabolism and immune response. BAs regulation of immunity…